Dosimetric comparison of manual forward planning with uniform dwell times versus volume-based inverse planning in interstitial brachytherapy of cervical malignancies.

Siddanna R Palled, Nikhila K Radhakrishna, Senthil Manikantan, Hashmath Khanum, Bindu K Venugopal, Lokesh Vishwanath
Author Information
  1. Siddanna R Palled: Radiation Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.
  2. Nikhila K Radhakrishna: Radiation Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.
  3. Senthil Manikantan: Medical Physicist, Kidwai Memorial Institute of Oncology, Bengaluru, India.
  4. Hashmath Khanum: Radiation Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.
  5. Bindu K Venugopal: Radiation Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.
  6. Lokesh Vishwanath: Radiation Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.

Abstract

AIM: Dosimetic comparison of manual forward planning(MFP) with inverse planning(IP) for interstitial brachytherapy(ISBT) in cervical carcinoma.
BACKGROUND: Brachytherapy planning by MFP is more reliable but time-consuming method, whereas IP has been explored more often for its ease and rapidness. The superiority of either is yet to be established.
METHODOLOGY: Two plans were created on data sets of 24 patients of cervical carcinoma who had undergone ISBT, one by MFP with uniform dwell times and another IP on BrachyVision 13.7 planning system with a dose prescription of 600 cGy. Isodose shaper was used for improving conformity & homogeneity. Dosimetric parameters for target and organs at risk (OARs) were recorded. Conformity index (COIN), dose homogeneity index (DHI), overdose index (OI), Coverage index (CI) and dose nonuniformity ratio (DNR) were calculated.
RESULTS: Mean high risk clinical target volume: 73.05(±20.7)cc, D90: 5.51 Gy vs. 5.6 Gy ( = 0.017), V100: 81.77 % vs. 83.74 % ( = 0.002), V150: 21.7 % vs. 24.93 % ( = 0.002), V200: 6.3 % vs. 6.4 % (0.75) for IP and MFP, respectively. CI: 0.81(IP) and 0.83(MFP) ( = 0.003); however, COIN was 0.79 for both plans. D2cc of OARs was statistically better with IP (bladder 54.7 % vs. 56.1 %,  = 0.03; rectum 63 % vs. 64.7 %, ( = 0.0008).
CONCLUSION: Both MFP and IP are equally acceptable dosimetrically. With higher dose achieved to the target, for a similar OAR dose, MFP provides greater user flexibility of dwell positions within the target as well as better optimization. Isodose shaper may be carefully used for fine tuning. Larger sample sizes and clinical correlation will better answer the superiority of one over the other.

Keywords

References

  1. Indian J Cancer. 2018 Jul-Sep;55(3):238-241 [PMID: 30693886]
  2. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):955-61 [PMID: 17889277]
  3. ISRN Oncol. 2014 Jan 23;2014:125020 [PMID: 24587919]
  4. Brachytherapy. 2013 Nov-Dec;12(6):637-44 [PMID: 23850274]
  5. J Med Phys. 2014 Jul;39(3):197-202 [PMID: 25190999]
  6. J Med Phys. 2006 Apr;31(2):89-94 [PMID: 21206671]
  7. Phys Med. 2017 Dec;44:58-65 [PMID: 29254592]
  8. Acta Oncol. 2014 Aug;53(8):1012-8 [PMID: 24975370]
  9. Int J Radiat Oncol Biol Phys. 1993 Jun 15;26(3):519-27 [PMID: 8514547]
  10. Radiother Oncol. 2005 Mar;74(3):235-45 [PMID: 15763303]
  11. J Contemp Brachytherapy. 2010 Dec;2(4):163-170 [PMID: 27853479]
  12. Rep Pract Oncol Radiother. 2015 Sep-Oct;20(5):365-9 [PMID: 26549994]
  13. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):820-7 [PMID: 18455325]
  14. Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):515-24 [PMID: 9457842]
  15. J Appl Clin Med Phys. 2010 Jul 12;11(3):3227 [PMID: 20717091]
  16. Med Phys. 2009 Jun;36(6):2136-53 [PMID: 19610303]
  17. Radiother Oncol. 2006 Jan;78(1):67-77 [PMID: 16403584]
  18. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1270-4 [PMID: 16253782]
  19. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):537-9 [PMID: 24411631]
  20. J Contemp Brachytherapy. 2017 Feb;9(1):89-98 [PMID: 28344609]
  21. Brachytherapy. 2011 Jul-Aug;10(4):306-12 [PMID: 21030317]
  22. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):111-9 [PMID: 23849695]

Word Cloud

Created with Highcharts 10.0.0%planningMFPIPvs = 07dosetargetindex0forwardbrachytherapycervicaldwellbettercomparisonmanualinverseinterstitialISBTcarcinomaBrachytherapysuperiorityplans24oneuniformtimesIsodoseshaperusedhomogeneityDosimetricriskOARsCOINclinical581830026optimizationAIM:DosimeticBACKGROUND:reliabletime-consumingmethodwhereasexploredofteneaserapidnesseitheryetestablishedMETHODOLOGY:TwocreateddatasetspatientsundergoneanotherBrachyVision13systemprescription600cGyimprovingconformity&parametersorgansrecordedConformityDHIoverdoseOICoverageCInonuniformityratioDNRcalculatedRESULTS:Meanhighvolume:7305±20ccD90:51 Gy6 Gy017V100:7774V150:2193V200:3475respectivelyCI:003however79D2ccstatisticallybladder5456103rectum63640008CONCLUSION:equallyacceptabledosimetricallyhigherachievedsimilarOARprovidesgreateruserflexibilitypositionswithinwellmaycarefullyfinetuningLargersamplesizescorrelationwillanswerotherversusvolume-basedmalignanciesindicesInterstitialInverseManual

Similar Articles

Cited By (1)